3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
6
Recruiting
3
Unknown
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
17
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Other
1
Myeloid
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
903
Lung Neoplasms
490
Small Cell Lung Carcinoma
140
Neoplasms
111
Melanoma
107
Neoplasm Metastasis
105
Breast Neoplasms
99
Colorectal Neoplasms
94
Ovarian Neoplasms
76
Carcinoma, Renal Cell
64
Pancreatic Neoplasms
62
Squamous Cell Carcinoma of Head and Neck
58
Mesothelioma
53
Stomach Neoplasms
51
Head and Neck Neoplasms
47
Adenocarcinoma of Lung
46
Triple Negative Breast Neoplasms
45
Esophageal Neoplasms
40
Colonic Neoplasms
40
Brain Neoplasms
40
Sarcoma
38
Mesothelioma, Malignant
38
Prostatic Neoplasms
37
Urinary Bladder Neoplasms
36
Recurrence
30
Carcinoma, Transitional Cell
28
Uterine Cervical Neoplasms
25
Endometrial Neoplasms
25
Carcinoma, Hepatocellular
21
Carcinoma, Squamous Cell
19
Interventions
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Venous Thromboembolism
×
Thoracic
×
Clear all
NCT03090880
2022-11-17
PROVE
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
59 enrolled